In this issue:
Epigenetic vs. intensive chemotherapy in older newly diagnosed AML
Infectious complications in MBL
First-line FC-R dose intensification for CLL
High-dose vincristine sulfate liposome injection for Ph-ve ALL
Effects of obesity on induction chemotherapy in newly diagnosed AML
GnRH agonist for preventing of chemotherapy-induced POF
Early death in NHL
R-CHOP vs. CHOP-RIT for previously untreated follicular NHL
Rituximab maintenance after ASCT in relapsed CD20+ DLBCL
R-CHOEP-14 vs. R-MegaCHOEP in high-risk aggressive DLBCL
Please login below to download this issue (PDF)